GSK Stock Recovers, Rises Around 17% YTD: Time to Buy, Sell or Hold?

GSK (GSK) stock has risen 16.9% year to date compared with an increase of 7.0% for the industry. The stock has also outperformed the sector and the S&P 500 index, as seen in the chart below. The stock has also been trading above 200 and 50-day moving averages since early March.GSK Stock Underperforms Industry, Sector and S&PImage Source: Zacks Investment ResearchThe main driver of the stock’s recovery in 2025, following the 8.7% dip in 2024, was the increase in its long-term sales outlook for 2031, as annou ...